CollPlant Biotechnologies CLGN
NASDAQ CLGN
$0.31 +0.01 (+4.06%)
As of: Aug 21, 2026 · 3:59 PM EDT

CollPlant Biotechnologies (CLGN) Other Non Operating Income (2018 - 2021)

CollPlant Biotechnologies' (CLGN) quarterly Other Non Operating Income came in at -$42.0 million in Q3 2021, down 110.0% YoY from $420.0 million in Q3 2020, and down 107592.31% on a QoQ basis from -$39000.0 in Q2 2021.

CollPlant Biotechnologies (CLGN) Other Non Operating Income (2018 - 2021) Analysis & Trends

CollPlant Biotechnologies (CLGN) has 4 years of Other Non Operating Income data on file, last reported at -$42.0 million in Q3 2021.

  • Quarterly Other Non Operating Income fell 110.0% year-over-year to -$42.0 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was -$49.8 million (down 155.85% YoY) and the FY2020 annual result came in at $181000.0, down 21.3% from the prior year.
  • Other Non Operating Income slipped to -$42.0 million in Q3 2021, from -$39000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $511000.0 in Q4 2019 to a low of -$42.0 million in Q3 2021.
  • A 4-year average of -$4.6 million and a median of -$65000.0 in 2020 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2019 — Other Non Operating Income jumped 755.13% — and 2020, when it tumbled 51182.05%.
  • Tracing CLGN's Other Non Operating Income over 4 years: stood at -$78000.0 in 2018, then jumped by 755.13% to $511000.0 in 2019, then slumped by 1630.14% to -$7.8 million in 2020, then plunged by 437.15% to -$42.0 million in 2021.
  • The last three Other Non Operating Income figures came in at -$42.0 million (Q3 2021), -$39000.0 (Q2 2021), and $67000.0 (Q1 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CollPlant Biotechnologies 4.26 Mn 4.26 Mn -243,000.00

Historic Data

Download Data
DateValue
Sep 30, 2021 -42.00 Mn
Jun 30, 2021 -39,000.00
Mar 31, 2021 67,000.00
Dec 31, 2020 -7.82 Mn
Sep 30, 2020 -20.00 Mn
Jun 30, 2020 -65,000.00
Mar 31, 2020 93,000.00
Dec 31, 2019 511,000.00
Sep 30, 2019 -39,000.00
Jun 30, 2019 -111,000.00
Mar 31, 2019 -131,000.00
Dec 31, 2018 -78,000.00
Sep 30, 2018 -109,000.00
Jun 30, 2018 -40,000.00
Mar 31, 2018 143,000.00